PLD

Here's a Quick Look Into the Fundamentals of Prologis Stock

More and more people are talking about Prologis over the last few weeks. Is it worth buying the Specialty Real Estate Investment Trust stock at a price of $133.37? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • Prologis has moved 14.8% over the last year, and the S&P 500 logged a change of 21.5%

  • PLD has an average analyst rating of buy and is -4.67% away from its mean target price of $139.9 per share

  • Its trailing earnings per share (EPS) is $3.14

  • Prologis has a trailing 12 month Price to Earnings (P/E) ratio of 42.5 while the S&P 500 average is 15.97

  • Its forward earnings per share (EPS) is $2.61 and its forward P/E ratio is 51.1

  • The company has a Price to Book (P/B) ratio of 2.3 in contrast to the S&P 500's average ratio of 2.95

  • Prologis is part of the Real Estate sector, which has an average P/E ratio of 25.55 and an average P/B of 2.1

  • PLD has reported YOY quarterly earnings growth of -40.9% and gross profit margins of 0.8%

  • The company has a free cash flow of $4.94 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At September 30, 2023, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (114 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 6,700 customers principally across two major categories: business-to-business and retail/online fulfillment.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS